Purpose: To update the 2008 International Classification of Corneal Dystrophies (IC3D) incorporating new clinical, histopathologic, and genetic information. Methods: The IC3D reviewed worldwide peer-reviewed articles for new information on corneal dystrophies published between 2008 and 2014. Using this information, corneal dystrophy templates and anatomic classification were updated. New clinical, histopathologic, and confocal photographs were added.
Results: On the basis of revisiting the cellular origin of corneal dystrophy, a modified anatomic classification is proposed consisting of (1) epithelial and subepithelial dystrophies, (2) epithelialstromal TGFBI dystrophies, (3) stromal dystrophies, and (4) endothelial dystrophies. Most of the dystrophy templates are updated. The entity "Epithelial recurrent erosion dystrophies" actually includes a number of potentially distinct epithelial dystrophies (Franceschetti corneal dystrophy, Dystrophia Smolandiensis, and Dystrophia Helsinglandica) but must be differentiated from dystrophies such as TGFBI-induced dystrophies, which are also often associated with recurrent epithelial erosions. The chromosome locus of Thiel-Behnke corneal dystrophy is only located on 5q31. The entity previously designated as a variant of Thiel-Behnke corneal dystrophy on chromosome 10q24 may represent a novel corneal dystrophy. Congenital hereditary endothelial dystrophy (CHED, formerly CHED2) is most likely only an autosomal recessive disorder. The so-called autosomal dominant inherited CHED (formerly CHED1) is insufficiently distinct to continue to be considered a unique corneal dystrophy. On review of almost all of the published cases, the description appeared most similar to a type of posterior polymorphous corneal dystrophy linked to the same chromosome 20 locus (PPCD1). Confocal microscopy also has emerged as a helpful tool to reveal in vivo features of several corneal dystrophies that previously required histopathologic examination to definitively diagnose.
INTRODUCTION Dedication
We dedicate this work to the memory of Gordon K. Klintworth, MD, PhD, a brilliant ophthalmic pathologist, and a highly esteemed member of the International Committee for Classification of Corneal Dystrophies (IC3D), whose legacy of excellence in corneal research and teaching is legendary.
International Committee for the Classification of Corneal Dystrophies
In 2008, the first IC3D report sought to develop a "new classification system for corneal dystrophies" through integration of the then current information on phenotype, pathology, and especially genetics. 1 This project was initially undertaken to correct the shortcomings of the century-old phenotypic method of corneal dystrophy classification.
Cornea Dystrophy: History and Definition
In 1890, the term corneal dystrophy was introduced into the literature by Groenouw 2 and then by Biber. 3 Groenouw reported 2 patients with "noduli corneae," although he did not distinguish between the one patient having granular corneal dystrophy (GCD) and the other having macular corneal dystrophy (MCD). Subsequently, Biber described a patient with lattice corneal dystrophy (LCD). Thereafter, Fuchs, 4 Uhthoff, 5 and Yoshida 6 continued to use the term "corneal dystrophy."
The general term corneal dystrophy describes an inherited disorder that affects, singly or in combination, cells, tissues, and/or organs. 1 In ophthalmology, corneal dystrophies have typically referred to a group of inherited disorders that are usually bilateral, symmetric, slowly progressive, and not related to environmental or systemic factors. 7 There are exceptions to each part of the dystrophy definition. Epithelial basement membrane dystrophy (EBMD) and central cloudy dystrophy of François (CCDF) are likely degenerative rather than hereditary conditions in the majority of patients. Corneal dystrophies can also be clinically unilateral, for example, posterior polymorphous corneal dystrophy (PPCD). Systemic changes are occasionally seen as in Schnyder corneal dystrophy (SCD), where hypercholesterolemia is common.
Another challenge is that it is unclear where to draw the dividing line between hereditary bilateral essentially stationary corneal diseases such as cornea plana (from mutations in keratocan) and the hereditary bilateral diseases called corneal dystrophies. This is underscored by the entity, posterior amorphous corneal dystrophy (PACD) (from deletion of keratocan together with 3 other genes), which is typically minimally progressive and can be associated with iris abnormalities. Consequently, many would agree that the term corneal dystrophy may have more historic than practical meaning. However, we have chosen to follow custom, and in this second edition of IC3D, we have continued to address only entities that have been traditionally included in corneal dystrophies.
Keratoconus-Is It a Corneal Dystrophy?
Do the corneal ectatic diseases, keratoconus and pellucid marginal degeneration, meet the criteria for inclusion in corneal dystrophies? This is a complex and controversial discussion.
The choice to include keratoconus in a corneal dystrophy classification could be supported by the emerging suggestion of a genetic basis. There is a family history in 10% of cases, increased prevalence in first-degree relatives of affected individuals, and markedly increased prevalence in trisomy 21. Keratoconus is likely genetically heterogeneous and may have incomplete penetrance and variable expressivity. [8] [9] [10] [11] [12] [13] However, most cases of keratoconus are sporadic, and in contrast to established corneal dystrophies, potential causative associations such as eye rubbing and atopy are noted. There is still insufficient evidence demonstrating a clear genetic basis in the majority of patients with keratoconus. For this reason, the IC3D continues to support exclusion of corneal ectasias from the corneal dystrophy classification. As interest in molecular etiology of keratoconus continues, we anticipate future new insights into the true genetic basis of this highly prevalent corneal disease.
Shortcomings of the Historic Corneal Dystrophy Classification
There were numerous flaws in the traditional and most widely used corneal dystrophy classification system. 14, 15 Some of the dystrophies were named before the advent of the slit lamp, whereas most were described before the development of genetic mapping. Introduction of genotyping revolutionized our knowledge base of corneal dystrophies. Genotyping revealed both genotypic heterogeneity, that is, a single dystrophy such as Meesmann corneal dystrophy is associated with different genes (KRT3 and KRT12) and with phenotypic heterogeneity, the TGFBI gene is associated with multiple distinct allelic dystrophy phenotypes, Reis-Bücklers corneal dystrophy (RBCD), Thiel-Behnke corneal dystrophy (TBCD), granular corneal dystrophy type 1 (GCD type 1), granular corneal dystrophy type 2 (GCD type 2), and classic lattice corneal dystrophy (LCD). 1 The IC3D classification system attempts to address these critically important shortcomings.
Dystrophy Versus Degeneration and Other Questions
As noted previously, a number of entities formerly considered as corneal dystrophies are more likely degenerations rather than inherited diseases. For example, the majority of epithelial basement membrane dystrophy (EBMD) cases have no hereditary basis. Central cloudy dystrophy of François (CCDF), although hereditary in a few families, is phenotypically identical to posterior crocodile shagreen. The only distinction is that CCDF is associated with a family history. There are only a few publications describing an entire family with CCDF. [16] [17] [18] Hence, in descriptions of CCDF patients without a detailed family history, it is impossible to exclude the diagnostic possibility of posterior crocodile shagreen degeneration. 19 Fuchs endothelial corneal dystrophy (FECD) is a very common corneal dystrophy and has a familial basis. 20, 21 Stage 1 FECD consists of only cornea guttata without corneal decompensation. Not all patients with stage 1 FECD progress. Are nonprogressive corneal guttae evidence of a corneal degeneration rather than FECD? The answer is not known but has important clinical implications. Often, the patient with cornea guttata is informed of having a diagnosis of FECD. If the individual consults the Internet or other sources, their research will inevitably suggest that FECD is a disease that often progresses to corneal edema, visual loss, and surgical intervention. Thus, a premature diagnosis of FECD in the absence of a family history, genetic evidence, or corneal edema can have important adverse psychological impact on the patient who anticipates future visual loss and need for corneal transplantation surgery.
Other dystrophies were described decades ago with minimal or unclear clinical information and no genetic information. In particular, such dystrophies as Grayson- Wilbrandt might be variants of other well-known dystrophies or might not even exist.
Misleading dystrophy names have also contributed to misdiagnosis. Among individuals with the disease formerly named Schnyder crystalline corneal dystrophy (SCCD), 50% actually have visible crystalline deposits. 22 Correct diagnosis of those affected patients in the absence of crystals often confounded even seasoned clinicians who depended on this flawed assumption coupled with erroneous literature, both supporting the notion that crystals were integral to the diagnosis. 23, 24 Indeed, the compounded errors of SCD were the major impetus to create the IC3D nomenclature revision group in 2005. Because the 2008 IC3D publication observed "once established in textbooks, it is exceedingly difficult to purge incorrect information about rare diseases. Many myths are perpetuated because very few ophthalmologists have seen a substantial number of the unusual corneal dystrophies." Even experienced corneal subspecialists often were unable to correctly diagnose those with acrystalline SCD 24 and patients went undiagnosed for decades.
Formation of the IC3D in 2005 Leading to Publication in 2008
Initially, the first requirement for membership in the IC3D group was extensive firsthand knowledge and experience in examining patients with one or more distinct corneal dystrophies. In this way, each dystrophy could be discussed and analyzed by those who had seen the disease rather than solely being informed by published descriptions, which might be erroneous. The group was to critically assess the published literature to purge errors. The members were also necessarily international to assess geographically distinctive founder effects on globally distinct population. Although SCD was extremely common in central Massachusetts in the United States and the west coast of Finland, GCD type 2 was extremely common in Korea. In some cases, the IC3D was fortunate to include the individual who originally described the dystrophy, as in Lisch epithelial corneal dystrophy (LECD) and X-linked endothelial corneal dystrophy. The second requirement for membership in the IC3D was representation from geneticists and ophthalmic pathologists.
The 2008 IC3D publication contained the traditional anatomic classification that organized dystrophies according to the corneal layer that was chiefly affected. 14, 15 Templates for each dystrophy were created in a standard format to summarize clinical, pathological, and genetic information as well as representative clinical photographs.
An evidence-based category system was suggested by Professor Gordon K. Klintworth, MD, PhD, to indicate the level of evidence supporting existence of a given corneal dystrophy depending on how substantive was the knowledge of its clinical, pathological, and genetic basis. He postulated that existence of a new corneal dystrophy must begin with identification of a clinical phenotype and should progress to characterization of the causative gene mutation.
An example of a monogenic category 1 dystrophy is SCD, which is caused by mutations in 1 gene, UBIAD1. Another category 1 dystrophy PACD is caused by deletion of multiple genes, keratocan (KERA), lumican (LUM), decorin (DCN), and epiphycan (EPYC). The genetic basis of other dystrophies, such as some types of FECD, may prove to be complex and involve multiple genes.
These categories were specified as follows:
"Category 1: A well-defined corneal dystrophy in which the gene has been mapped and identified and the specific mutations are known.
Category 2: A well-defined corneal dystrophy that has been mapped to one or more specific chromosomal loci, but the gene(s) remains to be identified. Category 3: A well-defined corneal dystrophy in which the disorder has not yet been mapped to a chromosomal locus.
Category 4: This category is reserved for a suspected, new, or previously documented corneal dystrophy, although the evidence for it, being a distinct entity is not yet convincing." 1 We postulated that with increased knowledge about a dystrophy, its category should progress over time from 4 to 3 to 2 to 1. Suspected dystrophies that remain category 4 because no further information ever becomes available may be eventually removed from the nomenclature. The group did not further specify specific criteria for removal of a category 4 dystrophy.
Corneal Dystrophy Purgatory and the Category 4 Dilemma-When Can a Category 4 Dystrophy Be Eliminated?
In some cases, additional information might show that a category 4 dystrophy is not an independent entity. One such example is central discoid corneal dystrophy (CDCD). 25, 26 This category 4 dystrophy was phenotypically indistinguishable from acrystalline SCD. When the causative gene for SCD was found to be UBIAD1, 27, 28 genetic testing of CDCD similarly demonstrated mutations in UBIAD1 indicating that CDCD was not a unique dystrophy. CDCD was consequently removed before publishing the first IC3D classification, in which it was reclassified as SCD variant. 26 Should elimination also be considered for a category 4 corneal dystrophy in which no further information to prove or disprove its unique existence is forthcoming? In such a case, there is no evidence to substantiate or to disprove the existence of the dystrophy. We consider this the equivalent of corneal dystrophy "purgatory."
A case in point is Grayson-Wilbrandt, a category 4 dystrophy, which was described in 1 publication in 1966 supported only by artist's renditions of phenotype, without clinical photographs or genotyping. 29 Over the ensuing 4 decades, while no subsequent articles have disputed the original publication, there also have been no articles substantiating these findings. Most members of the IC3D agreed that this entity should be eliminated from the classification. It is now being consigned to a category of "Removed Dystrophies" (Table 1 ) so that in the event a future publication seems to substantiate the existence of this entity, the reference publication remains readily retrievable for future use.
Has the IC3D Been Accepted?
The IC3D 2008 classification system successfully integrated the then most currently accurate clinical, pathological, and genetic information regarding corneal dystrophies. The nomenclature has been incorporated by the American Academy of Ophthalmology's widely used Basic and Clinical Science Course Series, 30 which instructs ophthalmology residents in the United States and Europe and has been referenced by the National Eye Institute. Nonetheless, the recommendations of the IC3D have been incorporated only in a minority of new publications. They had been cited 114 times by July 2014, according to Thomson Reuters' Web of Science, as opposed to about 800 articles published on corneal dystrophies since 2009. It is unclear whether the editors and reviewers reject the new classification, think it unimportant, or remain creatures of habit. For example, despite the nomenclature revision to GCD type 2, the name Avellino is still used, although its prevalence is seemingly decreasing. Recognizing that change is an evolutionary process, such incremental progress is encouraging.
Revising the IC3D Nomenclature
The nomenclature revision was configured to be userfriendly and easily accessible to physicians and patients on www.corneasociety.org and open access through the journal Cornea. One stated requirement of the original nomenclature revision was that it be easily "upgradeable." Six years after the original publication, sufficient new information had become available to begin our first revision of the IC3D.
Changes in the 2015 IC3D Anatomic Classification Change
The traditionally accepted "anatomic level" corneal dystrophy classification has limitations, 14, 15 as dystrophies were solely assigned to the single layer most affected. Yet RBCD and TBCD affect not only the subepithelial area with destruction of the Bowman layer but also the anterior stroma and later the deeper stroma. Although categorized anatomically as "Bowman layer dystrophies," TGFBI dystrophies affect multiple layers. Other corneal dystrophies also affect more than 1 layer. MCD affects both the stroma and endothelium, and SCD involves epithelium, stroma, and endothelium. As we understand the primary cell(s) of origin, it may be less important to categorize dystrophies as being confined to 1 specific layer. In addition, histopathology, although affording improved resolution at the cellular level, is also subject to individual case and disease stage variation.
In this revision of the original IC3D from 2008, we include a proposed alteration of the century-old anatomic level classification to more accurately reflect involvement of the cellular layers. We now exclude the Bowman acellular layer and Descemet acellular membrane. Dystrophies are now divided into epithelial and subepithelial dystrophies, epithelial-stromal TGFBI dystrophies, stromal dystrophies, and endothelial dystrophies ( Table 1) .
What We Have Removed and Added
The IC3D elected to remove the extensive table of gene loci and genes with specific mutations because this information is rapidly changing and can be more easily obtained on the Internet. For similar reasons, a table of mutations is not included in this revision although templates still include the gene locus and gene.
The classic articles on corneal dystrophy classification by Waring, Rodrigues, and Laibson 14, 15 included clinical drawings and histopathologic photographs. As clinicopathological correlation remains a hallmark of corneal dystrophy diagnosis, we have included representative histopathology and electron microscopy, as well as confocal microscopy in some cases. Findings on the emerging technique of anterior segment optical coherence tomography (OCT) were added to the templates when available. We expect that this method will refine clinical diagnostics of several dystrophies, especially the differential diagnosis between TBCD and RBCD by providing images that are highly similar to histopathologic sections.
Reclassified Corneal Dystrophies

Congenital Hereditary Endothelial Dystrophy
One challenge of the dystrophy nomenclature has been the tendency to emphasize a new or rare observation instead of waiting for a complete analysis of a new disorder. In the 2008 IC3D publication, we observed that "inconsistencies in the literature have confounded our understanding of precise findings in specific corneal dystrophies." Since then, we have learned more about congenital hereditary endothelial dystrophy (CHED). In 2008, we followed convention by including 2 types of CHED: an autosomal dominant (AD) form with less severe findings was called CHED1 and an autosomal recessive (AR) form with more severe findings was termed CHED2. Further review of the clinical and pathological descriptions of the 5 families previously reported with CHED1 suggests that many and possibly all of these families have PPCD. [31] [32] [33] Consequently, AD CHED (CHED1) has been eliminated. Autosomal recessive CHED, previously called CHED2, is now called simply CHED. 34 Is the 10q23-24 Dystrophy Distinct or a Variant of TGFBI Thiel-Behnke Corneal Dystrophy?
In 1997, Yee et al 35 reported a dystrophy affecting the Bowman layer that mapped to 10q23-24, which they called Thiel-Behnke corneal dystrophy (TBCD). The article suggested that the affected individual had corneal findings consistent with TBCD. The histological features of this patient were subsequently reported by Lohse et al 36 ; however, there were different pedigrees in both articles. Clarification of the 10q Thiel-Behnke phenotype 37 presented other challenges. Nakamura et al 38 described a mixture of honeycomb-like, geographic-like, and map-like opacity patterns of the presented patients in their legends, but these were not compatible with the accompanying black and white photographs that did not demonstrate a typical honeycomb-like pattern. Consequently, given the genetic heterogeneity, phenotypic heterogeneity and absence of corroborating histopathology of the 10q23-24 dystrophy, we believe that there is insufficient evidence to consider this a variant of TBCD. Is it a distinct dystrophy? Because this is not presently known, we hope ongoing investigations will resolve this uncertainty before the next IC3D revision. The 10q23-24 dystrophy is thus still listed as a footnote to TBCD and not promoted to a template.
Expanded Templates
In 2008, the epithelial recurrent erosion dystrophy template included both Franceschetti 39 hereditary recurrent erosion and Dystrophia Smolandiensis (DS), 40 which shared recurrent erosions as their major and often only clinical finding. At that time, it was unclear whether these 2 entities were variants of the same condition or whether these were distinct dystrophies. Lisch et al 41 observed that the affected members of the original Franceschetti's family showed recurrent erosions in the first decades, as well as diffuse subepithelial opacities in the advanced age. The authors termed this entity "Franceschetti corneal dystrophy" (FRCD). In 2009, another entity, Dystrophia Helsinglandica (DH) 42 was published and has been added to the epithelial recurrent erosion dystrophy's template. Future information, especially future identification of the underlying gene(s) will reveal whether these 3 entities are unique entities or allelic variants of one and the same disorder.
Diagnosis of a Corneal Dystrophy in the Pediatric Patient
Diagnosing corneal dystrophies in the pediatric patient remains a challenge. Most publications contain photographs of the most classic advanced cases found in adults. Few photographs document the earliest and most subtle corneal changes as would occur in children, and there is no atlas of corneal dystrophy findings in children. This markedly increases the difficulty of making the correct diagnosis in the pediatric patient. 43, 44 Sporadic Corneal Dystrophy?
It is important to be cautious before making the diagnosis of a sporadic corneal dystrophy. It is mandatory to obtain the family history and examine the parents and other family members. For example, paraproteinemic immunotactoid keratopathy can mimic SCD, lattice corneal dystrophy, or GCD type 1. 45 Mucolipidosis IV can cause a cornea verticillata pattern similar to GCD type 1.
A PLEA TO REVIEWERS AND EDITORS
More Stringent Criteria for Publishing the New Unique Corneal Dystrophy An 8-year-old boy is examined and noted to have an unusual configuration of bilateral corneal flecks. Is this a unique new corneal dystrophy? There is a systematic approach to determining whether this is a corneal dystrophy that has already been described or rather a unique new entity.
Do other family members have similar corneal findings? If so, the inheritance is likely AD or X-linked. Even if there is no family history, family members should still be examined to detect subtle or previously unappreciated corneal changes. If no abnormalities are evident, the inheritance could be AR or there could be incomplete penetrance or poor expressivity. Although a classical phenotype-genotype correlation facilitates diagnosis, this does not always occur. Histopathology and genotyping can add more information.
If geneticists discover a new mutation, a novel type of corneal dystrophy can be constructed phenotypically. We advise peer-reviewed journals to strengthen the criteria required for publication of a "new" corneal dystrophy. A minimum of approximately 10 affected members in 3 generations is reasonably convincing to demonstrate a distinct dominant phenotype clinically and scientifically. Such a rigorous systematic approach also avoids creation of more category 4 dystrophies that may be destined only for eventual elimination. Corneal photographs with a dilated pupil also facilitate diagnosis. When the gene or gene locus has been identified, it is preferable to include photographs with genetic confirmation. We have attempted to do both when possible for this article.
As an example, a 27-year-old woman demonstrated rare bilateral lattice lines atypical for classic LCD. Genotyping demonstrated the classical Arg124Cys TGFBI LCD1 mutation confirming LCD. This was not a unique corneal dystrophy but rather an additional example of phenotypic variation resulting from variable penetrance or expressivity of the gene.
Regarding mutations of TGFBI, a phenotype typical enough to be clinically recognizable is generally limited to TBCD, RBCD, GCD1, GCD2, and classic LCD. When any of these classic mutations is documented, corresponding terminology should be used without exception, despite any possible individual variation in phenotype. Other TGFBI mutations often produce variant, overlapping, or mixed phenotypes, often with amyloid, and these dystrophies can be called variant LCD by IC3D conventions. Also, it is ill appreciated that both Congo red and Masson trichrome often co-label some deposits in GCD1 and LCD, suggesting a mixed phenotype or GCD2. Also in these cases, the terminology corresponding to the identified mutation should simply be used.
There are frequent submissions to journals of such "new" dystrophies based on a small change in phenotype. More than a century away from the original description of corneal dystrophies, the field has progressed from phenotype to genotype. In the United States, support of the National Eye Institute has made genotyping more accessible through eye-GENE. 46 We implore authors and reviewers alike to require genotyping and phenotypic information before proposing the discovery of any new genetic disease.
EPITHELIAL AND SUBEPITHELIAL DYSTROPHIES
Epithelial Basement Membrane Dystrophy (EBMD)
Mendelian inheritance in man (MIM) #121820.
Former Alternative Names and Eponyms
Map-dot-fingerprint dystrophy. Cogan microcystic epithelial dystrophy. Anterior basement membrane dystrophy.
Inheritance
Isolated familial cases have been reported. However, because the majority of cases have no documented inheritance, they are considered to be degenerative or secondary to trauma.
Genetic Locus
5q31.
Gene
Transforming growth factor beta-induced-TGFBI in 2 families.
Onset
Commonly present in adult life. Rarely described in children.
Signs
Poor adhesion of basal epithelial cells to abnormal basal laminar material is thought to predispose to recurrent erosions.
Maps
Irregular islands of thickened, gray, hazy epithelium with scalloped, circumscribed borders, particularly affecting the central or paracentral cornea. Isolated or combined with other signs (Fig. 1A) .
Dots (Cogan)
Irregular round, oval, or comma-shaped, nonstaining, putty-gray intraepithelial opacities, clustered like an archipelago in the central cornea ( Fig. 1B ). Typically combined with other signs, especially with maps.
Fingerprint Lines
Parallel, curvilinear lines, usually paracentral, best visualized with retroillumination ( Fig. 1C ). Isolated or combined with other signs, especially maps.
Bleb Pattern (Bron)
Subepithelial pattern like pebbled glass, best seen by retroillumination ( Fig. 1D ). Isolated or combined with other signs.
Symptoms
EBMD can be asymptomatic, associated with painful erosive episodes and/or may cause decreased vision by inducing mild irregular astigmatism (monocular diplopia, "ghost" images).
Course
Location and degree of pathology can fluctuate with time.
Light Microscopy
Maps
Sheets of intraepithelial, multilamellar, basal laminar material ( Fig. 1F ).
Fingerprint Lines
Rib-like intraepithelial extensions of basal laminar material ( Fig. 1E ).
Dots
Intraepithelial pseudocysts containing cytoplasmic debris.
Bleb Pattern
Irregular, subepithelial accumulation of fibrillogranular material.
In contrast to some other superficial dystrophies, the Bowman layer is normal.
Transmission Electron Microscopy
Maps
Thick, multilamellar sheets (2-6 nm thick) of epithelial basement membrane that extend into the epithelium. intervening between distorted epithelium and the intact Bowman layer) to form redundant sheets corresponding to maps (E) and fingerprint lines (F) (E, Masson trichrome; F, PAS, bar = 200 mm.) G, In vivo confocal microscopy demonstrates abnormal hyperreflective intraepithelial basement membrane material within suprabasal and basal epithelial cell layers (400 · 400 mm).
Fingerprint Lines
Fine fibrillar (17 nm diameter) and granular (8 nm) substance in addition to undulating waves of the basement membrane.
Dots
Intraepithelial pseudocysts contain degenerating cells with pyknotic nuclei and cytoplasmic debris.
Blebs
Discrete noncystic mounds of abnormal granular material deposited between the epithelium and Bowman layer that indents the overlying basal epithelial cells. May mimic cysts clinically, but no cysts present on histology.
Confocal Microscopy
Maps
Highly reflective tissue in various configurations corresponds to abnormal basement membrane extending into the intermediate and basal epithelial cell layers. Adjacent basal epithelial cells appear distorted. No abnormalities in superficial epithelial cells or stroma.
Fingerprint Lines
Linear hyperreflective structures corresponding to abnormal basement membrane projecting into the corneal epithelium ( Fig. 1G ).
Dots
Hyperreflective structures with sharp border within the intermediate cell layers.
Blebs
Circular or oval hyporeflective or hyperreflective areas at the level of the basal epithelium and Bowman layer.
Category
Most cases are sporadic and may be degenerative. Category 1 in rare cases. Note: Only 1 publication identifies 2 families with EBMD with TGFBI mutations.
Epithelial Recurrent Erosion Dystrophies (EREDs)
MIM #122400.
Variants
Franceschetti corneal dystrophy (FRCD). Dystrophia Smolandiensis (DS). Dystrophia Helsinglandica (DH).
Inheritance
Autosomal dominant.
Genetic Locus
Unknown.
Gene
Onset
Early childhood.
Signs
Recurrent epithelial corneal erosions presenting in the first decades of life lasting 1 to 7 days. During pain-free intervals, no biomicroscopically evident changes are present ( Fig. 2A ). By mid-life, diffuse, central, subepithelial opacity, subepithelial fibrosis ( Fig. 2B ), or protruding keloid-like formations develop.
Symptoms
Severe epithelial erosive attacks commence in childhood and recur throughout life. The attacks often start at night. Visual impairment from central corneal opacification consequent to erosions occurs in approximately 50% of cases.
By age 30 to 40 years, corneal erosions become less severe and less frequent.
Course
With advancing age to 30 to 40 years, slow reduction in frequency of painful erosive episodes. Slow progression of central opacities impairs visual acuity.
Light Microscopy
FRCD
Based on superficial perilimbal biopsy, irregular basal epithelium with enlarged intercellular spaces. Alcian bluepositive deposits were present both intracellularly and intercellularly. Partial destruction and absence of the Bowman layer with intervening avascular connective tissue pannus between the basal epithelium and Bowman layer ( Fig. 2C ). Negative Congo red staining.
DS
Keloid-like structure stains positive with Congo red indicating secondary amyloidosis.
Transmission Electron Microscopy
FRCD
Irregularity in size and shape of the basal epithelial cells and enlarged intercellular clefts corresponding to Alcian blue-positive deposits. Presumably "dystrophic" mitochondria in between basal epithelial cells. Pannus contains numerous fibroblasts (Fig. 2D ).
Immunohistochemistry
FRCD
Segmental reduced expression of the tight junction proteins claudin and E-cadherin, desmosome components. Decorin expression seems to be enhanced in the basal epithelial layer compared with the normal postmortem cornea.
DS
Abundant fibronectin is present in the central subepithelial stroma, localized in areas of subepithelial fibrosis. Keratocytes in these areas are immunoreactive for S100 calcium-binding protein A4 (S100A4).
Confocal Microscopy
DS
Abnormal thinning of the corneal epithelium, absence of the Bowman layer with accumulation of pathological material at the level of the Bowman layer. Subepithelial corneal nerves are sparse and tortuous.
Category
3.
Note: The difference in severity of corneal opacification in FRCD, DS, and DH could be explained by the presence of polymorphism and difference in expressivity of a common gene. The term "Familial recurrent corneal erosions" is descriptive and not diagnostic as recurrent erosions frequently occur in other corneal dystrophies. Future DNA analyses will reveal more information about FRCD, DS, and DH and assist with differential diagnosis. 
Former Alternative Names and Eponyms
None.
Inheritance
Autosomal dominant inheritance most likely, but X-linked inheritance not excluded.
Genetic Locus
Gene
Onset
First decade of life.
Signs
Diffuse bilateral subepithelial opacities and haze, most dense centrally (Fig. 3A ).
Symptoms
Painful episodes of recurrent corneal erosions, which decrease during adolescence (only 1 publication of a single family).
Course
Progressive loss of vision in adolescence.
Light Microscopy
Subepithelial band of eosinophilic, periodic acid-Schiff (PAS)-positive, Alcian blue-positive, hyaluronidase-sensitive material is present anterior to the Bowman layer ( Fig. 3B ).
Transmission Electron Microscopy
Subepithelial deposits of fine fibrillar material.
Immunohistochemistry
Subepithelial deposits react for chondroitin-4-sulfate and dermatan sulfate.
Confocal Microscopy
Not reported. 
Former Alternative Names and Eponyms
Juvenile hereditary epithelial dystrophy.
Variant
Stocker-Holt variant.
Inheritance
Genetic Loci
Locus 12q13 (KRT3) Locus 17q12 (KRT12) Stocker-Holt variant. 
Onset
Signs
Multiple, tiny intraepithelial vesicles extend to the limbus and are most numerous in the interpalpebral area with clear surrounding epithelium. Direct illumination shows varying diffuse gray opacities in different patterns, which may have a distinct border (Fig. 4A ). Areas of the central or peripheral cornea may be unaffected. Whorled and wedge-shaped epithelial patterns have been reported. The gray opacities appear as solitary transparent cysts on indirect illumination (Figs. 4B, C). Approximately 85% of eyes show microcysts affecting the entire epithelium, while the remainder are localized in the upper, lower, central, and/or peripheral cornea. Coalescence of several cysts may result in refractile linear opacities with an intervening clear cornea. The cornea may be slightly thinned and corneal sensation may be reduced.
Stocker-Holt Variant
The entire cornea demonstrates fine grayish punctate epithelial opacities that stain with fluorescein and fine linear opacities that may appear in a whorl pattern.
Symptoms
Patients are typically asymptomatic or may have mild visual reduction, although some patients complain of glare and light sensitivity. Foreign body sensation or tearing may escalate to painful recurrent epithelial erosions. Rarely, blurred vision results from corneal irregularity and scarring. 
Stocker-Holt Variant
Patients demonstrate more severe signs and symptoms with earlier onset compared with classic Meesmann corneal dystrophy.
Course
Stationary or slowly progressive.
Light Microscopy
The thickened and disorganized epithelium always demonstrates intraepithelial cysts (Fig. 4D) filled with PASpositive cellular debris, which fluoresces. The cells also contain of PAS-positive and diastase-sensitive material (glycogen). A thickened multilaminar basement membrane projects into the basal epithelium.
Stocker-Holt Variant
Variably thickened epithelium with vacuolated and degenerating cells. Variably thickened basement membrane extends into the epithelium. The Bowman layer and stroma remain normal.
Transmission Electron Microscopy
Intracytoplasmic "peculiar substance" represents a focal collection of fibrogranular material surrounded by tangles of cytoplasmic filaments (Fig. 4E ). These cysts are round and uniform (10-50 mm) . Some lesions with reflective points in the cytoplasm probably correspond to cell nuclei.
Stocker-Holt Variant
Not reported.
Confocal Microscopy
Hyporeflective areas in the basal epithelium ranging from 40 to 150 mm in diameter, some with reflective spots inside ( Fig. 4F ).
Numerous corneal intraepithelial microcysts and hyperreflective material thought to represent degenerative cells have been detected closer to the basal layer of the corneal epithelium in older patients. Compared with the basal epithelial layer, the superficial layer contains larger microcysts with atrophic changes of the hyperreflective material. Clearly visualized demarcation lines between the microcysts and normal epithelial cells correspond to the biomicroscopically visible demarcation between clear and affected areas.
Stocker-Holt Variant
Former alternative names and eponyms
Band-shaped and whorled microcystic dystrophy of the corneal epithelium.
Inheritance X-chromosomal dominant.
Genetic Locus
Xp22.3.
Gene
Onset
Childhood.
Signs
Direct illumination shows localized gray opacities in different patterns: whorl-like, radial, band-shaped flame/ feathery, and club shaped (Figs. 5A, B ). Indirect illumination demonstrates multiple densely crowded clear cysts (Fig. 5C ). Opacities can be minimal or asymmetric with clear surrounding epithelium. Similar appearance in males and females.
Symptoms
Asymptomatic or blurred vision if the pupillary axis is involved. 
Light Microscopy
Epithelial basal cells are cuboidal with low nuclear to cytoplasmic ratio. In the suprabasal and parabasal layers, vacuolated cells (Fig. 5D ) progress to the epithelial surface, where they adopt elongated flat squamous shapes. These vacuoles are PAS positive, diastase labile, Luxol fast blue and Sudan black negative, consistent with glycogen. Intercellular cysts, parakeratosis, orthokeratosis, and hyperkeratosis are not identified.
Transmission Electron Microscopy
Basal epithelial cells with intact basement membrane and hemidesmosomes are unremarkable. In the midlevel and superficial epithelium, there are cells with myriad vacuoles and inclusions (Fig. 5E ) of 2 forms; vaguely flocculent or lamellar material with or without a circumscribing membrane, and more electron-dense whorled or membranous structures.
Confocal Microscopy
There are 4 characteristic features of the abnormal epithelial cells: highly hyperreflective cytoplasm and hyporeflective nuclei (Fig. 5F) ; uniform involvement of all epithelial layers within the affected areas; welldemarcated borders with adjacent normal epithelium; involvement of the limbal area. No distinct intracellular deposits are present, although the cytoplasm has granular hyperreflectivity. 
Former Alternative Names and Eponyms
Subepithelial amyloidosis. Primary familial amyloidosis (Grayson) .
Inheritance
Autosomal recessive.
Genetic Locus
1p32.
Gene
Tumor-associated calcium signal transducer 2 (TACSTD2, previously M1S1).
Onset
First to second decade.
Signs
Initially, subepithelial lesions may appear similar to bandshaped keratopathy (Fig. 6A ) or there may be groups of small multiple nodules, that is, mulberry configuration ( Fig. 6B ). They stain with fluorescein ( Fig. 6C) , indicating epithelial hyperpermeability. Superficial vascularization is frequently seen. In later life, patients may also develop stromal opacification or develop larger nodular, kumquat-like lesions (Fig. 6D) although it is uncertain whether there is a transition of the 4 different phenotypes from one to the other with time.
Symptoms
Significant decrease in vision, photophobia, irritation, redness, and tearing.
Course
Progression of protruding subepithelial deposits and stromal opacity. Most patients develop recurrence after superficial keratectomy, lamellar keratoplasty, or penetrating keratoplasty, typically within a few years.
Light Microscopy
Subepithelial and stromal amyloid deposits (Fig. 6E ).
Transmission Electron Microscopy
Disruption of epithelial tight junctions in the superficial epithelium. Amyloid evident in the basal epithelial layer.
Immunohistochemistry
Deposits stain with antibodies to lactoferrin.
Confocal Microscopy
Epithelial cells are irregular in shape and often elongated. There is a mild disorganization of the overall epithelial architecture. Large accumulations of brightly reflective material are noted within or beneath the epithelium and within the anterior stroma. No evident abnormalities can be detected in the posterior cornea. 
EPITHELIAL-STROMAL TGFBI DYSTROPHIES
Reis-Bücklers Corneal Dystrophy
MIM #608470.
Former Alternative Names and Eponyms
Corneal dystrophy of Bowman layer, type I (CDB I). Geographic corneal dystrophy (Weidle) . Atypical Granular Corneal Dystrophy. Granular Corneal Dystrophy, type 3. Anterior limiting membrane dystrophy, type 1. Superficial Granular Corneal Dystrophy.
Inheritance
Genetic Locus
Gene
Transforming growth factor beta-induced-TGFBI.
Onset
Signs
Confluent early irregular geographic-like opacities with varying densities develop at the level of the Bowman layer and superficial stroma, initially discrete ( Fig. 7A ) and subsequently extending to the limbus and deeper stroma (Fig. 7B ). Can be confused with TBCD especially in the first 2 decades. In this early stage, RBCD shows more irregular diffuse opacities with clear interruptions, whereas TBCD exhibits multiple flecks with reticular formation.
Symptoms
Vision is impaired from childhood. Painful recurrent corneal erosions.
Course
Slowly progressive deterioration of vision. Recurrent corneal erosions tend to abate with time. Similar but frequently more aggressive course than TBCD but may not be able to distinguish in an individual case.
Light Microscopy
The Bowman layer is replaced by a sheet-like layer of granular Masson trichrome-red deposits (Fig. 7C) , which can extend to the subepithelial stroma and, in advanced cases, sparse round deposits appear in the middle and posterior stroma.
Transmission Electron Microscopy
Subepithelial electron-dense, rod-or trapezoidal-shaped bodies identical to those in GCD1 (Fig. 7D) replace the Bowman layer and extend from the basal epithelial cell level to anterior stroma and, sparsely, to deeper stroma. Basal epithelial cells may contain vesicles with similar rods. Electron microscopy is necessary for definitive histopathologic diagnosis to distinguish from TBCD, which demonstrates curly fibers not rod-shaped bodies.
Immunohistochemistry
Rod-shaped bodies are immunopositive for transforming growth factor beta-induced protein (keratoepithelin). (Arg124Leu TGFBI mutation), bar = 200 mm. D, Electron microscopy: broad band of irregularly arranged, subepithelial rod-shaped bodies (·3000). E, In vivo confocal microscopy shows a granular highly reflective material without any shadow within the basal epithelium (Arg124Leu mutation) (400 · 400 mm).
Optical Coherence Tomography
A homogenous confluent layer of hyperreflective deposits often with serrated anterior border is apparent at the level of the Bowman layer and anterior stroma. It is thickest in the center (72-132 mm), becomes thinner in midperiphery, and disappears toward the limbus.
Confocal Microscopy
Distinct deposits are found in the epithelium and Bowman layer. The deposits in the suprabasal and basal epithelial cell layer show extremely high reflectivity from small granular or amorphous material without shadows (Fig. 7E) . The Bowman layer is replaced by highly reflective irregular material, even more reflective than in TBCD. Fine diffuse round or spindle-shaped deposits may be noted in the anterior and sparsely even in the posterior stroma.
Thiel-Behnke Corneal Dystrophy (TBCD) MIM #602082.
Former Alternative Names and Eponyms
Corneal dystrophy of Bowman layer, type II (CDB2). Honeycomb-shaped corneal dystrophy. Anterior limiting membrane dystrophy, type II. Curly fibers corneal dystrophy. Waardenburg-Jonkers corneal dystrophy.
Inheritance
Genetic Loci
Gene
Onset
Signs
Initial signs are solitary flecks or irregularly shaped scattered opacities at the level of the Bowman layer, followed by symmetrical subepithelial honeycomb opacities (Figs. 8A, B, Ci) with peripheral cornea typically uninvolved. In older patients, opacities can progress to deeper stromal layers and the corneal periphery. It is difficult to distinguish from Reis-Bücklers corneal dystrophy (RBCD) in early or individual cases.
Rare alleles that combine Arg555Gln with other TGFBI mutations lead to variants of TBCD with atypical opacities.
Symptoms
Recurrent corneal erosions may be painful in the first and second decades. Gradual visual impairment develops later. Erosions are less frequent, and the onset of visual impairment is later than in RBCD.
Course
Slowly progressive deterioration of vision results from increasing corneal scarring. Recurrent corneal erosions diminish with time. Similar but frequently less aggressive course than RBCD but difficult to distinguish individual cases.
Light Microscopy
Alternating irregular thickening and thinning of the epithelial layer to compensate for ridges and furrows of underlying stroma, with focal absence of the epithelial basement membrane (Fig. 8D) . The Bowman layer is replaced by a superficial fibrocellular pannus with a pathognomonic wavy sawtoothed pattern.
Transmission Electron Microscopy
Presence of curly collagen fibers 9 to 15 nm in diameter (Fig. 8E) , importantly distinguishes TBCD from RBCD.
Immunohistochemistry
Curly fibers are immunopositive for transforming growth factor beta-induced protein (keratoepithelin).
Confocal Microscopy
Distinct deposits are found in the epithelium and Bowman layer. The deposits in the basal epithelial cell layer show homogeneous reflectivity with round edges accompanying dark shadows (Fig. 8F) . The Bowman layer is replaced with reflective irregular material that is less reflective than in RBCD.
Optical Coherence Tomography
Prominent hyperreflective material at the level of the Bowman layer extending into the epithelium in a characteristic FIGURE 8 . Lattice Corneal Dystrophy, type 1 (LCD). A, Initial signs of mild honeycomb appearance. B, Intensive honeycomb opacity pattern in advanced disease (Arg555Gln mutation). C, In a 42year-old with genetically confirmed TBCD: (i) the cornea displays honeycomb opacity while (ii) confocal microscopy demonstrates the sawtooth pattern of hyperreflective material in the Bowman layer. D, Light microscopy: varying thickness of the epithelium due to a thickened abnormal subepithelial fibrous layer (arrowheads) that replaces the Bowman layer and has a characteristic sawtooth-like surface. Masson trichrome, bar = 200 mm. E, Transmission electron microscopy: subepithelial curly filaments with a thickness of 10 nm (·50,000). F, In vivo confocal microscopy image shows abnormal hyperreflective material with homogeneous reflectivity, round edges, and dark shadows within the basal epithelium (400 · 400 mm). sawtooth pattern (Fig. 8Cii ), a major feature in distinguishing TBCD from RBCD.
Category
1.
Note: Linkage to 10q24 has been reported in 1 family. The initial and later descriptions of the phenotype are incomplete and variable, and light microscopic, immunohistochemical, and anterior segment optical coherence tomographic evidence of subepithelial scarring similar to and consistent with TBCD has not been published. 
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Gene
Onset
Signs
The first signs are central superficial fleck-like opacities that usually develop by the end of the first decade (Fig. 9A) . In retroillumination, isolated peripheral, few, and subtle lattice lines in deeper layers are visible initially in the superficial stroma of the same patient (Fig. 9B ). Thin branching refractile lines and/or subepithelial, whitish, ovoid dots also develop by the end of the first decade. These lines start centrally and more superficially, spreading centrifugally and deeply, but leaving the far peripheral stroma, Descemet membrane and the endothelium uninvolved (Figs. 9C, D) . Diffuse subepithelial ground-glass haze of the central and paracentral cornea develops concurrently with the lattice lines in the central and paracentral cornea and subsequently progresses (Fig. 9C) , accompanied by recurrent erosions. Development of diffuse central haze in the second to third decade may reduce vision sufficiently to necessitate surgical intervention. The number of lattice lines may differ between the 2 eyes (unilateral cases are described). Variant LCD, type IIIA also shows central thicker lattice lines (Fig. 10A) , whereas LCD, type IV is characterized more by deeper deposits without epithelial erosion (Fig. 10B ).
Symptoms
Ocular discomfort, pain, and visual impairment, sometimes start as early as the first decade as consequent to frequent recurrent erosive attacks. Visual impairment within the fourth decade.
Light Microscopy
Epithelial atrophy and disruption with degeneration of basal epithelial cells, focal thinning, or absence of the Bowman layer, progress with age. Eosinophilic amyloid material accumulates between the epithelial basement membrane and Bowman layer. Stromal deposition of amyloid distorts the architecture of corneal lamellae. Amyloid deposits characteristically stain positive with Congo red (Fig. 9E) , and display birefringence and red-green di rhos under polarized light (Fig. 9F) . Also, deposits exhibit metachromasia with crystal violet and fluorescence with the use of thioflavin T staining. FIGURE 9 . Lattice corneal dystrophy, type 1 (classic lattice). Direct (A) and retroillumination (B) of early lattice corneal dystrophy (LCD) with dots and fine lattice lines with genetic confirmation of Arg124Cys in TGFBI. C, Subepithelial groundglass haze of the central and inferior cornea, and diffuse lattice lines in advanced LCD with genetic confirmation of Arg124Cys in TGFBI. D, Dots and paracentral lattice lines in retroillumination with genetic confirmation of Arg124Cys in TGFBI. E, Light microscopy: Congo red (E) prominently stains a continuous layer of amyloid (asterisk) that underlies and partially destroys the Bowman layer and intrastromal amyloid deposits corresponding to lattice lines (arrowheads). F, This same section viewed with polarized light confirms deposits are birefringent and red-green dichroic, thus amyloid. Arg124Cys TGFBI mutation, bars = 200 mm. G, In vivo confocal microscopy image shows filaments corresponding to lattice lines within the stroma (400 · 400 mm). Figure 9D from Figure 10A 
Transmission Electron Microscopy
Extracellular masses of fine, electron-dense randomly aligned fibrils of uniform 8 to 10 nm diameter are characteristic of amyloid protein. There are fewer keratocytes in the areas of amyloid deposition: some are degenerated with cytoplasmic vacuolization, whereas others appear metabolically active. Descemet membrane and the endothelium are normal.
Confocal Microscopy
Linear and branching structures (Fig. 9G ) in stroma with changing reflectivity and poorly demarcated margins. Such lines must be differentiated from other similar images (ie, fungi).
Category
1.
Note: The LCD variants (Figs. 10A, B) are caused by more than 2 dozen distinct heterozygous amyloidogenic mutations, nearly all of which are located in the fourth FAS1 domain of TGFBI. LCD variants (previously designated type IIIA, I/IIIA, IV, and polymorphic amyloidosis) have a delayed onset compared with classic LCD. The lattice lines may be larger, with a limbus to limbus ropy appearance (type IIIA), thinner (type I/IIIA), smaller (type IV) or even absent (polymorphic amyloidosis), although one has to keep in mind that the lattice pattern is very much dependent on age and mutation. Some patients do not have clinically evident lattice lines. Corneal epithelial erosions are a typical presenting sign of LCD, types IIIA and I/IIIA, but are virtually absent in others (type IV and polymorphic corneal amyloidosis). The frequency of recurrent erosions is more common in subtypes that progress from anterior to posterior (types IIIA and I/IIIA) compared with those progress from posterior to anterior (type IV). Although classic LCD has been found in numerous countries, LCD variants are mostly geographically restricted. For example, LCD type IIIA and LCD type IV were reported predominantly in Japan and Italy, and the 2 LCD type IV variants were reported to be derived from solitary founder mutations in Japan and Italy.
Historically, multiple subtypes of lattice were created on the basis of phenotypic and genotypic variations. The so-called lattice corneal dystrophy type 2 (LCD2) is a misnomer, in fact comprising systemic amyloidosis plus corneal lattice lines and should be termed familial amyloidosis, Finnish type, or gelsolin type. Eponymously, it is known as Meretoja syndrome (Figs. 11A, B) . 
Former Alternative Names and Eponyms
Corneal dystrophy Groenouw type I.
Inheritance
Genetic Locus
Gene
Onset
Childhood, as early as 2 years of age.
Signs
In children, a vortex pattern (Fig. 12A ) of brownish granules develops superficial to the Bowman layer. As the patient ages, well-defined granules appear white on direct illumination with clear intervening stroma (Fig. 12B) . The size and number of granules increase resulting in snowflake appearance (Fig. 12C and D) . On retroillumination, these granules are composed of extremely small, translucent dots with the appearance of vacuoles, glassy splinters, or crushed bread crumbs. Opacities do not extend to the limbus. In later life, granules extend into the deeper stroma approaching Descemet membrane. Homozygotes have more severe manifestations.
Symptoms
Glare and photophobia are early symptoms. Visual acuity decreases as opacification progresses with age. Recurrent erosions are seen frequently. Homozygote cases have more severe symptoms.
Course
With progression, opacities become more confluent in the superficial cornea and reduce visual acuity. Serial observation over time demonstrates in both GCD1 and GCD2 that granule drop out after epithelial erosions may actually result in stromal clearing.
Light Microscopy
Multiple stromal deposits may extend from deep epithelium to Descemet membrane. Hyaline opacities stain with Masson trichrome (Fig. 12E ).
Transmission Electron Microscopy
Dense rod-shaped bodies are similar in appearance to those in Reis-Bücklers corneal dystrophy.
Immunohistochemistry
Abnormal deposits react with antibodies to transforming growth factor beta-induced protein (keratoepithelin).
Confocal Microscopy
Abnormal hyperreflective opacities in snowflake and trapezoidal shapes. , type 1 (GCD1) . A, In a child, early subepithelial verticillate-like opacities are evident by retro and direct illumination. B, With broad slit illumination, stromal deposits are both discrete and confluent, and are axially distributed in anterior stroma. C and D, In an adult, more prominent diffuse granular opacities in the form of "snowfall" are apparent with direct (C) and retroillumination (D). E, Light microscopy-Masson trichrome highlights deposits of keratohyalin at various stromal layers and partial destruction of the Bowman layer (between arrowheads). Arg555Trp TGFBI mutation, bar = 240 mm. Figures 12B and C 
Former Alternative Names and Eponyms
Avellino dystrophy Combined granular-lattice dystrophy For nearly a century, this entity was considered a mild GCD variant (Groenouw type I). Bücklers, as early as 1938, described and depicted a large family with this phenotype. Fifty years later, Weidle published reporting the same patients and subdivided granular dystrophy according to subtle clinical differences. In 1988, Folberg et al. described the histopathology of both amyloid and hyaline deposits in such patients. In 1992, the clinical findings of these patients were published and termed Avellino corneal dystrophy. The term Avellino (the district of Italy where the initial published pedigree originated) came into popular and published usage but is now considered obsolete because of the dystrophy's global occurrence. Others have used the term combined granular-lattice dystrophy although the amyloid component is typically only apparent by histopathology and does not resemble lattice lines.
Inheritance
Genetic Locus
Gene
Onset
Homozygous patients have earlier onset with dystrophy diagnosed, as early as 3 years of age, compared with heterozygotes, who may be diagnosed as early as the age of 8. Most GCD2 is diagnosed during teens or during early adulthood.
Signs
In heterozygote, initial signs are subtle superficial stromal tiny whitish dots (Fig. 13A) , which typically develop small spokes or thorns. Some may be arranged linearly like a string of pearls. Later, all eyes show superficial whitish round patches that have moth-eaten centers so that they may even appear to be discoid or ringshaped. Most patients also develop spiky anterior to midstromal deposits that are star, icicle, or spider-shaped ( Fig. 13B ) and partially translucent in retroillumination (Fig.  13Bb ). Patients may also have entirely translucent short dash-like linear or dot-like deposits in the posterior stroma deep to the branching stromal opacities.
The short lines or dashes sometimes observed in GCD2 can be distinguished from lattice lines observed in classic LCD and most of its variants:
1. Dashes in GCD2 appear whiter, and lattice lines in LCD are more refractile. 2. Dashes in GCD2 rarely cross each other, while lattice lines in LCD characteristically intersect to result in the pathognomonic lattice configuration.
Consequent to epithelial erosions, spontaneous drop out of superficial granules results in clearing of the central zone of opacity, which also becomes thickened with recurrences. Ultimately, more superficial translucent flattened breadcrumb opacities coalesce in the sub-Bowman anterior stroma (Fig. 13C) .
Phenotypic expressivity varies considerably with patients manifesting only a few white dots, and others showing deposits throughout the stroma. Patients with GCD2 have fewer stromal opacities than those with GCD1. Homozygote patients initially demonstrate numerous small dots in the superficial cornea in early childhood. By adulthood, there are larger, very dense irregularly shaped opacities in the superficial stroma that become deeper with time ( Fig. 13D ).
Symptoms
Vision decreases with age as the central visual axis becomes affected. Pain accompanies epithelial erosions.
Course
Slowly progressive. Homozygotes demonstrate more rapid progression.
Light Microscopy
Corneal opacities extend from the basal epithelium to the deep stroma. There is deposition of both hyalin and amyloid and individual opacities stain with Masson trichrome and/or Congo red (Fig. 13E) . Homozygotes demonstrate more severe findings.
Transmission Electron Microscopy
Anterior stromal rod-shaped very electron-dense deposits are similar to those noted in GCD1. On higher magnification, the rod-shaped deposit is composed of extracellular masses of fine, electron-dense, highly aligned fibrils. Enlarged keratocytes of heterozygous corneal tissue demonstrate intracellular organelles while details of the intracellular organelles are barely discernible in normal cell cytoplasm. In heterozygous tissue, keratocytes contain many dilated or degenerative mitochondria and vesicles containing amorphous material.
An extremely common ultrastructural finding is the presence of randomly aligned fibrils of amyloid (see LCD template).
Homozygotes demonstrate more severe findings.
Confocal Microscopy
Reflective breadcrumb-like round deposits with welldelineated borders or highly reflective irregular trapezoidal deposits are present in the anterior stroma (similar to GCD1). FIGURE 13 . GCD, type 2 (GCD2). A, A 13-year-old with few white dots and genetic confirmation of GCD2. B, Direct and (Bb) retroillumination demonstrate branching, star-shaped, spiny, and ring-like deposits. C, Genetically confirmed GCD2 with superficial translucent flattened breadcrumb opacity beneath the Bowman layer. Denser icicles and disc-like and ring-like opacities. D, Genetically confirmed homozygote with denser and confluent opacities. E, Light microscopy-Masson trichrome stains sub-Bowman and anterior stromal keratohyalin deposits red (arrowheads). Note that the deeper stromal layers do not have keratohyalin granules (asterisk). In the deep stroma, small amyloid deposits stain with Congo red (inset), Arg124His TGFBI mutation (bar = 300 and 200 mm inset). F, In vivo confocal microscopy shows abnormal hyperreflective stromal deposits with a snowflake or trapezoidal shape within the corneal stroma (400 · 400 mm). Linear and branching deposits with changing reflectivity (Fig. 13F ) are observed (similar to those in LCD).
1.
Note: Injury to the central cornea results in exacerbation of this corneal dystrophy with accelerated opacification. Hence, laser in situ keratomileusis, photorefractive keratectomy, and laser assisted in situ epithelial keratomileusis are strongly contraindicated in this dystrophy. Usually, GCD2 exacerbated more after laser in situ keratomileusis than after laser assisted in situ epithelial keratomileusis or photorefractive keratectomy.
In heterozygous GCD2 patients, superficial phototherapeutic keratectomy (PTK) may be judiciously used to reduce visually significant anterior stromal haze, recognizing that repeated PTK treatments and possibly keratoplasty may be eventually required. In homozygous GCD2, PTK results in more rapid recurrence than in heterozygous GCD2. However, when intervention is indicated, repeated PTK can be used in an effort to postpone more definitive intervention by keratoplasty.
STROMAL DYSTROPHIES
Macular Corneal Dystrophy (MCD)
MIM #217800.
Former Alternative Names and Eponyms
Groenouw corneal dystrophy type II. Fehr speckled dystrophy.
Inheritance
Genetic Locus
16q22.
Gene
Carbohydrate sulfotransferase 6 gene-CHST6.
Onset
Signs
Initially, central, superficial, irregular whitish fleck-like opacities develop, which give the condition its name (Fig. 14A) ; and unlike GCD, these flecks involve the limbus and the deep stroma down to Descemet membrane (Fig. 14B ). Simultaneously, a progressive diffuse haze develops, which involves the entire corneal stroma (Fig. 14C) . The epithelium remains smooth, but occasionally develops corneal erosions.
The cornea is much thinner than normal. As the disorder progresses, Descemet membrane becomes grayer and develops guttate excrescences although endothelial decompensation rarely occurs.
Symptoms
Severe visual impairment occurs between 10 and 30 years of age. Corneal sensitivity is reduced. Photophobia and painful recurrent erosions can rarely occur.
Course
Slowly progressive.
Light Microscopy
Breaks in the Bowman layer. Glycosaminoglycans (GAGs) diffusely accumulate intracellularly and extracellularly throughout the corneal stroma. Unique to stromal dystrophies, Descemet membrane and endothelium are primarily involved, as evidenced by Descemet thickening and guttata plus endothelial staining with Hale colloidal iron or Alcian blue (Fig. 14D ).
Transmission Electron Microscopy
Keratocytes and endothelial cells stain positively for GAGs and contain vacuoles and lamellar bodies. The extracellular matrix contains focal and diffuse fibrillogranular GAGs.
Optical Coherence Microscopy
Time-domain and spectral domain OCT show hyperreflectivity throughout the corneal stroma corresponding to diffuse corneal clouding together with diffuse hyperreflective opacities especially in the Bowman layer. Spectral domain OCT is able to visualize early changes in the Bowman layer, while time-domain OCT reveals hyperreflective accumulations in the anterior corneal stroma and peripheral posterior cornea stroma.
Confocal Microscopy
Blurred limited accumulations of highly reflective deposits are seen in the basal epithelium and anterior and mid stroma (Fig. 14E ). Some of these may have dark striaelike images. Normal keratocytes may not be seen.
Additional Findings
Although clinically indistinguishable, 3 variants of MCD are distinguished on the basis of immunoreactivity of specific sulfated epitopes of antigenic keratan sulfates (AgKS) in the cornea and the serum.
• MCD type I: No AgKS reactivity in the cornea or in the serum.
• MCD type IA: Keratocytes manifest AgKS reactivity, but the extracellular material does not. Serum lacks AgKS. • MCD type II: All the abnormal deposits react positively with AgKS, and the serum has normal or lower levels of AgKS.
Note: Electron microscopic corneal findings in systemic mucopolysaccharidoses are similar to findings that are seen in macular dystrophy. However, on clinical examination and light microscopy, cornea findings demonstrate more diffuse and earlier opacification without flecks in mucopolysaccharidoses that show corneal involvement (especially Hurler, Hurler-Scheie, and Maroteaux-Lamy types). The decisive phenotypical difference between MCD and the mucopolysaccharidoses are the flecks, which appear in MCD.
Category
1.
Note: A single case of uniparental (maternal) isodisomy has been reported that represents the first evaluation in association with a corneal dystrophy. Because MCD is recessively inherited, 2 alleles need to carry a pathogenic mutation. In this case, the father has 2 normal CHST6 genes, and the mother has 1 normal and 1 mutated CHST6 gene. Because the child has 2 identical CHST6 gene mutations (homozygous), and nonpaternity was excluded, the only explanation is a duplication of the chromosome or locus carrying the mutated CHST6 from the mother.
Schnyder Corneal Dystrophy (SCD)
MIM #21800. 
Former Alternative Names and Eponyms
Inheritance
Genetic Locus
1p36.
Gene
UbiA prenyltransferase domain containing 1-UBIAD1.
Onset
Maybe as early as childhood, but diagnosis usually made by the second or third decade. Diagnosis may be further delayed in patients who have the acrystalline form of the disease.
Signs
Corneal changes are predictable on the basis of age. Patients 23 years or younger have ring-or disc-like central corneal opacity and/or central crowded commashaped subepithelial crystals (Figs. 15A, B) . Between 23 and 38 years of age, arcus lipoides is also noted (Fig. 15 C) . After the age of 38, midperipheral panstromal haze also develops, causing the entire cornea to appear hazy (Figs. 15D-F). Despite the former (now obsolete) name of SCCD, only 50% of patients demonstrate corneal crystals. Crystals may be unilateral, may rarely regress, and can occur late in the disease.
Symptoms
Visual acuity decreases, and complaints of glare increase with age. Although scotopic vision may be remarkably good (considering the slit-lamp appearance), photopic vision may be disproportionately decreased. Corneal sensation decreases with age. Both affected and unaffected members of the pedigrees may have hyperlipoproteinemia (type IIa, III, or IV).
Course
Although slowly progressive, the majority of patients older than 50 years have severe reduction of photopic vision.
Light Microscopy
Abnormal deposition of intracellular and extracellular esterified and unesterified phospholipids and cholesterol in basal epithelial cells, the Bowman layer, and stroma. As organic solvents and resins can dissolve lipids, staining for lipids [such as Oil Red O (Fig. 15G) or Sudan black] are facilitated by submitting fresh tissue for pathology, ensuring appropriate fixation for special stains. In addition, there are FIGURE 15. SCD. A, Central stromal opacity in early SCD without crystals in a patient with mutation in UBIAD1. B, Early subepithelial central crystalline deposit in a patient with mutation in UBIAD1. C, Central corneal opacity with arcus lipoides. D, Central corneal opacity, subepithelial crystalline ring, mid peripheral haze, and arcus lipoides. E, Noncrystalline central diffuse opacity pattern with clearer area centrally, mid peripheral haze and prominent arcus lipoides in a 39-year-old SCD patient with UBIAD1 mutation. F, Noncrystalline disc-like central opacity, mid peripheral haze and prominent arcus lipoides in a 72-year-old patient with SCD with UBIAD1 mutation. G, Light microscopy-Oil Red O stains innumerable tiny lipid droplets within the corneal stroma in a frozen section that has not undergone processing for paraffin embedding, which would dissolve the lipids and make the staining negative, bar = 100 mm. H, Electron microscopy: empty crystalline space within a basal cell representing cholesterol deposit dissolved during dehydration stage of embedding process ·10,000 (SCD with crystals). I, In vivo confocal microscopy (400 · 400 mm) shows abnormal hyperreflective homogeneous spindle-shaped deposits within the anterior stroma (SCD with crystals). Figure 15B and Figure 15C from Figure 15B single published reports of SCD corneas with positive Congo red staining, suggesting secondary amyloid deposition and another with the addition of Alcian blue staining suggesting secondary deposition of GAGs.
Transmission Electron Microscopy
Abnormal accumulation of intracellular and extracellular esterified and unesterified phospholipids and cholesterol are deposited in the epithelium (Fig. 15H ) in the Bowman layer and throughout the stroma. Endothelial lipid has rarely been reported.
Confocal Microscopy
Intracellular and extracellular highly reflective deposits may lead to eventual disruption of the basal epithelial/ subepithelial nerve plexus (Fig. 15I ).
Category
1.
Note: Although SCCD has been the more commonly used name for this entity, this has caused diagnostic confusion as only 50% of patients exhibit corneal crystals. Consequently, SCD should be the preferred name. If the ophthalmologist does not suspect SCD when performing keratoplasty, the opportunity to perform lipid stains may be lost if the corneal specimen is not preserved correctly (as specified above).
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Congenital Stromal Corneal Dystrophy (CSCD)
MIM #610048.
Former Alternative Names and Eponyms
Congenital hereditary stromal dystrophy.
Inheritance
Genetic Locus
12q21.33.
Gene
Decorin, DCN.
Onset
Congenital.
Signs
Diffuse, bilateral corneal clouding with flake-like whitish stromal opacities throughout the stroma (Fig. 16A) . The changes are equally pronounced in all areas of the cornea. The cornea surface is normal and without fluorescein staining or vascularization. Pachymetry demonstrates increased stromal thickness.
Symptoms
Moderate to severe visual loss. Photophobia occurs in a minority of patients.
Course
Nonprogressive or slowly progressive.
Light Microscopy
The stromal lamellae are irregularly separated and may contain amorphous material (Fig. 16B) .
Onset
Congenital or first years of life.
Signs
Subtle but distinctive, small, translucent, discoid opacities or discrete, flat, gray-white, dandruff-like, and sometimes ring-shaped opacities scattered sparsely throughout any level of the otherwise clear stroma (Figs. 17A, B ). Flecks may extend to the limbus and are best detected with slit beam or retroillumination. The epithelium, Bowman layer, Descemet membrane, and endothelium are not involved. Asymmetric or unilateral corneal involvement is possible.
Symptoms
Asymptomatic, occasionally slight photophobia or decreased corneal sensitivity.
Course
Nonprogressive.
Light Microscopy
Swollen, vacuolated keratocytes, which contain GAGs (staining with Alcian blue and colloidal iron) and complex lipids (demonstrated by Sudan black and Oil Red O).
Transmission Electron Microscopy
Some keratocytes show membrane-based inclusions with delicate granular material.
Optical Coherence Tomography
Flecks correspond to slightly brighter small areas.
Confocal Microscopy
Accumulation of hyperreflective 2-to 18-mm dot-like material in the normal-sized and enlarged stromal keratocyte nuclei. Inclusions in basal nerves and doughnut-or kidneyshaped 70-· 110-mm deposits have variably been reported.
Posterior Amorphous Corneal Dystrophy (PACD)
MIM #612868.
Former Alternative Names and Eponyms
Posterior amorphous stromal dystrophy. 
Onset
Often occurs in the first decade of life and has been noted as early as 16 weeks, suggesting congenital origin.
Signs
PACD presents as diffuse gray-white sheet-like opacities that can involve any layer of the stroma but are most prominent posteriorly (Fig. 18A) . The lesions can be centroperipheral, extending to the limbus, or peripheral, the latter with less pronounced findings and symptoms. Transparent stromal breaks are often present. Decreased corneal thickness (as thin as 380 mm) ( Fig. 18B ) and corneal flattening to less than 41 diopters with associated hyperopia are characteristic, particularly in the centroperipheral form. Descemet membrane and endothelium may be indented by the opacities, and focal endothelial abnormalities have been observed. Prominent Schwalbe line, fine iris processes, pupillary remnants, iridocorneal adhesions, corectopia, pseudopolycoria, and anterior stromal tags have been reported, particularly in patients with the centroperipheral pattern, but there is no association with glaucoma.
Symptoms
Visual acuity is mildly affected, usually better than 20/40.
Course
None or slowly progressive in the majority of cases.
Light Microscopy
Irregularity of the posterior stromal lamellae with colloidal iron staining, anterior to a thin Descemet membrane, and focal attenuation of endothelial cells (Fig. 18C ).
Transmission Electron Microscopy
There are abnormally oriented collagen fibers and abnormal keratocytes with disorganization of the posterior stromal lamellae. A fibrillar layer resembling stromal collagen fibers interrupts Descemet membrane. These findings are not pathognomonic of this dystrophy and may be found in other abnormalities. In 1 patient with more pronounced changes, additional subepithelial deposits and a thick collagenous layer posterior to Descemet membrane were present.
Confocal Microscopy
Microfolds and a hyperreflective layer in the posterior stroma are present. 
Category
Central Cloudy Dystrophy of François
MlM #217600.
Former Alternative Names and Eponyms
Inheritance
Unknown. Autosomal dominant inheritance is occasionally reported. May be phenotypically indistinguishable from posterior crocodile shagreen, which is a corneal degeneration.
Gene/Genetic Locus
Onset
First decade (youngest affected patient was 8 years old).
Signs
Fortuitous finding of cloudy central polygonal or rounded stromal opacities that fade anteriorly and peripherally and are surrounded by clear tissue (Fig. 19 ). The changes are indistinguishable from Vogt posterior crocodile shagreen.
Symptoms
Mostly asymptomatic.
Course
Light Microscopy
No description in familial cases. Faint undulating appearance of the deep stroma and positive staining for GAGs.
Transmission Electron Microscopy
No description in familial cases, therefore published pathology could represent posterior crocodile shagreen. Extracellular vacuoles, some containing fibrillogranular material and electron-dense deposits. Endothelial vacuoles with fibrillogranular material and a sawtoothed lamellar pattern have also been reported. 
Former Alternative Names and Eponyms
Endoepithelial corneal dystrophy.
Inheritance
Cases without known inheritance are most common. Some cases with AD inheritance reported. Genetic basis of FECD is complex and heterogeneous, demonstrating variable expressivity and incomplete penetrance.
Genetic Locus
Early-Onset FECD 1p34.3-p32 (FECD1).
Late-Onset FECD
Association has been reported to 13pter-q12.13 (FECD2), 18q21.2-q21.3 (FECD3), 20p13-p12 (FECD4), 5q33.1-q35.2 (FECD5), 10p11.2 (FECD6), 9p24.1-p22.1 (FECD7), and 15q25 (FECD8).
Gene
Early-onset FECD: collagen, type VIII, alpha-2, COL8A2.
Onset
Most cases begin in the fourth decade or later, but the early variant starts in the first decade. Both early and later onset forms have female predominance at a ratio of 2.5:1 to 3:1.
Signs
Cornea guttata starts centrally and spreads peripherally (stage 1) ( Fig. 21A ). Some patients demonstrate guttae but never progress to later stages, whereas others advance to endothelial decompensation and stromal edema (stage 2). Corneal endothelium has a beaten metal-like appearance with or without pigment dusting. Corneal guttae in late-onset FECD are larger than those seen in early-onset FECD. Descemet membrane is thickened. Stromal edema may progress to involve the epithelium causing intraepithelial and interepithelial edema (epithelial bullae); bullous keratopathy (stage 3) (Figs. 21B, C) . Subepithelial fibrosis, scarring, and peripheral superficial vascularization from chronic edema occur in long-standing cases (stage 4).
Symptoms
Intermittent reduced vision from epithelial/stromal edema. Visual acuity worse in the morning because of increased stromal/epithelial edema after overnight eye closure. Pain, photophobia, and epiphora due to epithelial erosions resulting from ruptured epithelial bullae. Progressive visual loss. Guttae alone may not cause corneal edema, and mild cornea edema may not result in decreased vision. More severe disease associated with decreased vision often has epithelial and stromal edema and fibrosis. 
Former Alternative Names and Eponyms
Posterior polymorphous dystrophy. Schlichting dystrophy.
Inheritance
Autosomal dominant. Isolated unilateral cases, with similar phenotype but no heredity. Gene PPCD 1: unknown. PPCD 2: collagen, type VIII, alpha-2 (COL8A2). PPCD 3: zinc finger E box-binding homeobox 1 (ZEB1).
Genetic Locus
Onset
Signs
Often asymmetric. Opacities of Descemet membrane and endothelium with characteristic morphologic features: geographic gray opacities; vesicular lesions, either single or grouped, often surrounded by gray circular opacity; parallel gray-white endothelial bands with white "flaky" material along the bands (railroad tracks), which may extend across the entire cornea (Figs. 22A-C). Occasional cases may be associated with diffuse opacification of Descemet membrane and multiple larger vesicular endothelial opacities. Both keratoconic and nonkeratoconic corneal steepening have been reported, with the majority of individuals with PPCD3 demonstrating corneal curvatures greater than 48.0 diopters in both eyes. Corneal edema may develop, necessitating corneal transplantation in approximately 20% to 25% of affected individuals. Peripheral iridocorneal adhesions in about 25% of cases and elevated intraocular pressure in about 15% of cases.
Symptoms
Endothelial alterations often asymptomatic. Visual impairment may develop secondary to corneal edema.
Course
Rarely congenital corneal clouding. Endothelial changes often unchanged over years. Possible slow progression of polymorphic vesicles and greater thickness of Descemet membrane over years and decades occasionally causing endothelial decompensation.
Light Microscopy
Descemet membrane with multiple layers of collagen on its posterior surface manifesting focal fusiform or nodular excrescences. Blebs, discontinuities, or reduplication of the endothelial cell layer (Fig. 22D ).
Transmission Electron Microscopy
The anterior banded portion of Descemet membrane is normal, although the posterior nonbanded portion may be (ii) show that the endothelium is replaced with flat epithelial-like cells that grow focally as more than 1 layer of cells (i; asterisk) and forms blisters (ii; arrowheads) and occasionally elevated strands. Posterior stroma may show pits or discontinuities in Descemet membrane (i; arrowhead), bar = 100 mm. E, In vivo confocal microscopy showing vesicular lesions and band-like structures with irregular edges within the endothelium associated with polymegethism of endothelial cells (400 · 400 mm). Figures 22A, B, markedly abnormal, demonstrating alterations in thickness, a multilaminar appearance and occasional guttae. Two types of collagenous tissue posterior to Descemet membrane form layers up to 25 nm thick. Affected endothelial cells display ultrastructural characteristics of epithelial cells, such as microvilli and desmosomes. Immunohistochemistry PPCD 1: positive with anti-CK7, CK8, CK18, and CK19 antibodies.
Confocal Microscopy
Vesicular lesions: rounded dark areas with some cell detail apparent in the middle giving a doughnut-like appearance ( Fig. 22E ). Multilayered nests of cells. "Railroad-track": band-like dark area with irregular edges enclosing some smaller lighter epithelial-like cells. Polymegethism of the endothelium. Ophthalmol. 1969; Kirkness, et al. Br J Ophthalmol. 1987; and Toma, et al. Hum Mol Genet. 1995) may have PPCD based on clinical, histopathologic, and electron microscopic analyses, although a higher percentage of affected individuals in this family demonstrate corneal edema, with an earlier onset and more significant edema compared with the majority of families with PPCD. Because linkage analysis in this family demonstrated linkage to the region of chromosome 20 that is common to 4 families with PPCD, it is probable that the family originally reported by Pearce et al also has PPCD1, with a more severe phenotype than that of other PPCD1 pedigrees. However, as it is possible that the corneal endothelial dystrophy in this family and PPCD1 are allelic variants, or are associated with mutations in 2 different genes in the common linked interval for these endothelial dystrophies, we support the use of the original name used by Pearce et al, congenital endothelial corneal dystrophy, to describe the condition in this family. Identification of the genetic basis of PPCD1 will allow definitive determination of whether PPCD1 and congenital endothelial corneal dystrophy are in fact the same. entity. Therefore, we have removed AD CHED, formerly known as CHED1, from our classification system, so that AR CHED formerly known as CHED2 will be renamed CHED.
Former Alternative Names and Eponyms
Maumenee corneal dystrophy.
Inheritance
Genetic Locus
20p13.
Gene
Solute carrier family 4, sodium borate transporter, member 11-(SLC4A11) gene mutations identified in 76% of CHED pedigrees screened in 1 publication.
Onset
Signs
Bilateral. Often asymmetric. Corneal clouding ranging from diffuse haze to ground-glass milky appearance with occasional focal gray spots (Figs. 23A, B) . Thickening of the cornea (can be 2-3 times the normal thickness) (Fig. 23C) . Rarely secondary subepithelial band keratopathy. Rarely elevated intraocular pressure. Endothelial cell count reduced significantly (about 10-fold as compared with age-matched controls).
Symptoms
Corneal clouding with blurred vision often accompanied by nystagmus. Minimal to no tearing or photophobia.
Course
Relatively stationary with little or no progression.
Light Microscopy
Diffuse epithelial and stromal edema (Fig. 23D) , defects in the Bowman layer, degenerated corneal endothelium with multinucleated sparse and atrophic endothelial cells, and a thickened laminated Descemet membrane (Fig.  23E ) due to abnormal and accelerated secretion by the endothelial cells.
Transmission Electron Microscopy
Multiple layers of basement membrane-like material on the posterior part of Descemet membrane. Degeneration of endothelial cells with many vacuoles. Stromal thickening with severe disorganization and disruption of the lamellar pattern.
Immunohistochemistry
Collagen types I, III and V within the posterior collagenous layer of Descemet membrane from fibroblastlike change of the endothelial cells. 2):S1-S42. man layer. Anterior stroma with irregularly arranged collagen lamellae. Irregular thickening of Descemet membrane with small excavations and pits. Loss of endothelial cells or atypical appearance (Fig. 24C ).
Transmission Electron Microscopy
Moon crater-like endothelial changes and subepithelial band keratopathy. Subepithelial accumulations of an amorphous granular material. Irregular thinning of the Bowman layer (up to 0.5 mm) with many interruptions and gaps. Thickening of Descemet membrane (20-35 mm) consisting of an abnormal anterior and posterior banded zone. Complete absence of the posterior nonbanded zone. Discontinuous endothelial layer with partly normal and partly degenerative appearing cells (Fig. 24D) . No evidence of desmosome-like adherent junctions between the cells or tonofilament bundles within the cytoplasm.
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